Of patients who discontinued due to side effects, 73% quit during weeks 4-12
Systemic side effects may include nausea, gastrointestinal upset, flushing, and, in rare cases, allergic reactions such as rash, hives, or anaphylaxis
The research evidence supporting BPC-157 spans over 100 peer-reviewed publications
Although MSCs therapy appears to be safe and well tolerated, donor heterogeneity, in vitro amplification, immunogenicity, and cryopreservation issues need to be addressed before MSCs are transferred from clinical trials to clinical treatment (Galderisi and Giordano 2014
Metabolic conditions People with diabetes or prediabetes can note that AOD 9604 does not impair glucose metabolism